Cook Islands plants show regenerative properties

A skin care product based on plants used in traditional Cook Islands remedies has been created by UNSW researchers who are also investigating the regenerative properties of the plants for use in wound and bone healing.

The TeTika cosmetics, developed with the company Cimtech's BioActive Cook Islands oil, incorporates traditional Cook Islands medicines.

TeTika means 'truth and integrity' in Cook Islands Maori.

In 2003, Dr Graham Matheson and UNSW Medicine's Professor Bill Walsh began investigating the regenerative properties of plants in partnership with the local traditional leaders.

Dr Matheson, who has completed a PhD at UNSW based on the project, founded a company that permits traditional owners to share in financial benefits from his research, which has received support from UNSW's commercialisation company, NewSouth Innovations. The company was most recently supported by Australia.

"The University and the traditional leaders and I entered into an agreement that is currently being discussed around the world at biodiversity forums as towards world's best practice in access and benefit sharing," Dr Matheson says.

Dr Matheson and Professor Walsh are now investigating that promote new and skin healing. Professor Walsh says research using the plants is a continued collaborative project.

Dr Matheson and UNSW are major shareholders in the company, Cimtech.

More information: tetika.com.au/

add to favorites email to friend print save as pdf

Related Stories

Water wonder

May 13, 2011

A brilliant water saving idea by UNSW engineering academics Greg Leslie and Bruce Sutton has impressed the judges on ABC TV’s New Inventors program.

Saltwater solution to save crops

Sep 11, 2008

Technology under development at the University of New South Wales could offer new hope to farmers in drought-affected and marginal areas by enabling crops to grow using salty groundwater.

Recommended for you

Pyridoxine-doxylamine drug safety data lacking

20 hours ago

(Medical Xpress)—The most commonly prescribed drug for pregnant women suffering from morning sickness in their first trimester does not prevent birth defects even though drug safety data says it does, according to research ...

FDA approves new type 2 diabetes drug

Apr 15, 2014

(HealthDay)—Millions of Americans with type 2 diabetes have a new treatment option with the U.S. Food and Drug Administration's approval Tuesday of a once-weekly injectable drug, Tanzeum.

User comments